Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
Clinical and Experimental Nephrology|November 1, 2015
Role of renin-angiotensin system inhibitors in retardation of progression of end-stage renal failure: a retrospective studyTomoyuki Murakami, Tamio Iwamoto, Gen Yasuda, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 5, 2002
Prevalence of constipation in continuous ambulatory peritoneal dialysis patients and comparison with hemodialysis patientsGen Yasuda, Kazuhiko Shibata, Toshikazu Takizawa, et al.Renal Failure|October 7, 2004
Safety and efficacy of fluvastatin in hyperlipidemic patients with chronic renal diseaseGen Yasuda, Tadashi Kuji, Kyoko Hasegawa, et al.Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 21, 2009
Loss of nocturnal decline of blood pressure in non-diabetic patients with nephrotic syndrome in the early and middle stages of chronic kidney diseaseDaisaku Andoh, Mayumi Kobayashi, Gen Yasuda, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 14, 2008
Relationship between silent brain infarction and chronic kidney diseaseMayumi Kobayashi, Nobuhito Hirawa, Keisuke Yatsu, et al.Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|November 30, 2012
Effect of renin-angiotensin system inhibitor on residual glomerular filtration rate in hemodialysis patientsYoko Itoh, Tetsuya Fujikawa, Yoshiyuki Toya, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 12, 2010
Silent brain infarction and rapid decline of kidney function in patients with CKD: a prospective cohort studyMayumi Kobayashi, Nobuhito Hirawa, Satoshi Morita, et al.Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|November 12, 2013
Loss of amino acids into dialysate during hemodialysis using hydrophilic and nonhydrophilic polyester-polymer alloy and polyacrylonitrile membrane dialyzersAtsuko Yokomatsu, Tetsuya Fujikawa, Yoshiyuki Toya, et al.Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|November 22, 2007
Sevelamer hydrochloride improves hyperphosphatemia in hemodialysis patients with low bone turnover rate and low intact parathyroid hormone levelsToshiharu Kokuho, Yoshiyuki Toya, Yoshiaki Kawaguchi, et al.Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 16, 2013
Angiotensin receptor blocker (ARB)-diuretic versus ARB-calcium channel blocker combination therapy for hypertension uncontrolled by ARB monotherapyJin Oshikawa, Yoshiyuki Toya, Satoshi Morita, et al.Pageof 3